Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Gene Ther. 2014 Feb 27;21(4):379–386. doi: 10.1038/gt.2014.7

Figure 1. Echocardiography Reveals No Differences in Cardiac Function among Animals with Heart Failure that Were Treated with AAV9.SERCA2a Alone or with AAV9.SERCA2a and Bortezomib.

Figure 1

A: Schematic illustration of the study design. B: There were no significant differences in septal and posterior wall thickness among the AAV9.Empty and AAV9.SERCA2a with and without bortezomib treated groups. C: There were significant decreases in LV end diastolic volume and LV end systolic volume in the AAV9.SERCA2a with and without bortezomib treatment, * = P<0.05.